1. P424 Uptake of a switching program for patients receiving intravenous infliximab and vedolizumab to subcutaneous preparations. (21st January 2022) Authors: Alice, H; Gemma, B; Selinger, C P Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗